All lobbying filings

MAYER BROWN LLP

MAYER BROWN LLP filed a Q3 report for NOVOCURE on October 19, 2026, reporting $10,000 in lobbying income.

Lobbying for NOVOCURE · Medical technology company.

All filings by MAYER BROWN LLP · Everything NOVOCURE has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Trade (domestic/foreign)

Issues related to Section 232 investigations.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem